CJ Bioscience announced on February 2 that it will promote the commercialization of personalized dietary solutions in the first half of this year, based on research data on the gut microbiome of Koreans.


CJ Bioscience Logo

CJ Bioscience Logo

View original image

CJ Bioscience recently established an analytical framework that systematically organizes changes in the composition and characteristics of gut microbiota according to age, through a full life-cycle gut microbiome analysis study involving healthy Korean adults. The study comprehensively analyzed the composition and characteristics of gut microbiota based on a cohort of 683 healthy individuals, distinguishing differences by gut type and age group.


In a joint CAR T-cell therapy study conducted with Samsung Medical Center and Kangwon National University, the gut microbiota and serum metabolites of patients were analyzed, revealing microbial signals and characteristics associated with therapeutic response and immune-related side effects. The research team highlighted that the composition of gut microbiota and the characteristics of metabolites produced by these microbes showed statistically significant correlations with treatment responses.


Through this research, the company is focusing on an approach that designs microbiota-accessible carbohydrates (MAC) tailored to each individual's gut condition. Instead of providing the same dietary fiber to everyone, the approach differentiates the types and characteristics of carbohydrates according to each person's gut microbiota composition and features.


The research results were released at the 2026 Winter Symposium of the Korean Society for Microbiology and Biotechnology and published in a recent issue of Blood Advances, the official journal of the American Society of Hematology.



A CJ Bioscience representative stated, "The long-term accumulation of Korean gut microbiome data has provided a scientific foundation for discussing dietary design tailored to individual gut conditions," adding, "We plan to actively promote the commercialization of personalized dietary solutions based on the MAC concept in the first half of this year."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing